Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Breast Neoplasms 51Neoplasms 36Lung Neoplasms 24Colorectal Neoplasms 24Prostatic Neoplasms 15Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Rectal Neoplasms 9Hematologic Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Anxiety Disorders 9Pancreatic Neoplasms 8Obesity 8Lymphoma 8Depression 8Endometrial Neoplasms 7Vulvar Neoplasms 6Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Melanoma 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Pain 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4Smoking Cessation 4Papillomavirus Infections 4

Interventions

Radiotherapy 9Cisplatin 8Fibroblast Growth Factor 7 6Low-Level Light Therapy 5angiotensin I (1-7) 4Radiation 4Injections 4Propolis 3Morphine 3Methotrexate 3Leucovorin 3Drug Therapy 3Cryotherapy 3glucarpidase 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Water 2Radiotherapy, Intensity-Modulated 2RRx-001 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Lidocaine 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mucositis × Methods × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡